We are live on ! Find out more
NEO icon

NeoGenomics

138 hedge funds and large institutions have $494M invested in NeoGenomics in 2016 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 62 increasing their positions, 37 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

899% more call options, than puts

Call options by funds: $1.08M | Put options by funds: $108K

68% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 37

2% more capital invested

Capital invested by funds: $483M → $494M (+$10.8M)

0% more funds holding in top 10

Funds holding in top 10: 66 (0)

11% less funds holding

Funds holding: 155138 (-17)

77% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 22

Holders
138
Holders Change
-17
Holders Change %
-10.97%
% of All Funds
3.67%
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.16%
New
5
Increased
62
Reduced
37
Closed
22
Calls
$1.08M
Puts
$108K
Net Calls
+$971K
Net Calls Change
+$291K

NEO Hedge Fund Activity: Q3 2016 in Review

138 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in NeoGenomics (NEO) for Q3 2016, worth a combined $494M — up 2.2% from $483M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of NEO and 5 opened new positions — a net loss of 17 holders — while 37 trimmed existing stakes and 62 added.

The largest buyer was Next Century Growth Investors, adding an estimated $4.18M. The largest seller was Kopp Investment Advisors, cutting an estimated $8.2M.

  • 138 institutional investors held NeoGenomics (NEO) as of Q3 2016, down from 155 in Q2 2016.
  • Funds reported $494M of NeoGenomics stock for Q3 2016, up 2.2% quarter-over-quarter.
  • 5 funds opened new NeoGenomics positions in Q3 2016 and 22 closed out, a net change of -17 holders.
  • The largest NeoGenomics buyer in Q3 2016 was Next Century Growth Investors, an estimated $4.18M added.
  • The largest NeoGenomics seller in Q3 2016 was Kopp Investment Advisors, an estimated $8.2M sold.

Based on aggregated 13F filings for Q3 2016.